Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan.
J Neuroimmunol
; 385: 578241, 2023 12 15.
Article
en En
| MEDLINE
| ID: mdl-37952282
ABSTRACT
This study included 51 patients with muscle-specific kinase antibody-positive myasthenia gravis (MuSK-MG) from a Japanese multicenter survey to examine clinical features and outcomes. Median onset age was 37 years and female predominance was observed. All patients developed generalized symptoms and almost all (50/51) patients had bulbar symptoms. About half of the patients met the criteria for refractory MG. The refractory group had a lower age of onset, higher severity scores, and higher maximum daily doses of oral prednisolone compared to the nonrefractory group. The outcomes for MuSK-MG patients in Japan are not favorable, indicating the need for more aggressive treatment.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Miastenia Gravis
Límite:
Adult
/
Female
/
Humans
/
Male
País/Región como asunto:
Asia
Idioma:
En
Revista:
J Neuroimmunol
Año:
2023
Tipo del documento:
Article
País de afiliación:
Japón